The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised


About TearScience

TearScience develops devices that provide clinical identification and treatment of evaporative dry eye. TearScience's integrated, in-office system enables eye care professionals to effectively address a root cause of evaporative dry eye. The company's LipiView is a device used for observing the tear film. LipiView captures images of the tear film, processing 14 million pixels per second - more than a billion data points in total - for precise evaluation in less than 5 minutes.

TearScience Headquarter Location

5151 McCrimmon Parkway Suite 250

Morrisville, North Carolina, 27560,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing TearScience

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

TearScience is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,689 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,900 items

TearScience Patents

TearScience has filed 79 patents.

The 3 most popular patent topics include:

  • Ophthalmology
  • Disorders of sclera and cornea
  • Diseases of the eye and adnexa
patents chart

Application Date

Grant Date


Related Topics




Ophthalmology, Diseases of the eye and adnexa, Disorders of sclera and cornea, Disorders of conjunctiva, Dog diseases


Application Date


Grant Date



Related Topics

Ophthalmology, Diseases of the eye and adnexa, Disorders of sclera and cornea, Disorders of conjunctiva, Dog diseases



  • When was TearScience founded?

    TearScience was founded in 2005.

  • Where is TearScience's headquarters?

    TearScience's headquarters is located at 5151 McCrimmon Parkway, Morrisville.

  • What is TearScience's latest funding round?

    TearScience's latest funding round is Acquired.

  • How much did TearScience raise?

    TearScience raised a total of $133.73M.

  • Who are the investors of TearScience?

    Investors of TearScience include Johnson & Johnson, EW Healthcare Partners, De Novo Ventures, Investor Growth Capital, General Catalyst and 5 more.

  • Who are TearScience's competitors?

    Competitors of TearScience include eSight, Cardiva Medical, PulmonX, Acelity, Powervision and 14 more.

You May Also Like

Ocusciences Logo

OcuSciences is developing a product to use images from the eye to detect diseases such as diabetes at an earlier stage.


BioResonator aims to measure eye pressure with the resonance frequency.


Realistic Eye aims to provide a more natural appearance for the 750,000 patients in the US with an artificial eye that does not dilate and therefore appears unnatural. RealisticEye achieves these results by introducing a dilating artificial eye.


Portaero, in stealth mode, is a medical devices firm, developing a device for the treatment of COPD (Chronic obstructive pulmonary disease).


Lumineyes uses a laser to heat the pigment layer of their eye to allow people with brown eyes to turn them permanently green or blue.

Valor Medical

Valor Medical is a San Diego-based medical device company that has developed liquid embrolic technology for the treatment of cerebral aneurysms.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.